Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expression

European Journal of Pharmacology

Volumn 370, Issue 3, 1999, Pages 329-336

  Karbowska, Joanna ^a   Kochan, Zdzislaw ^a   Zelewski, Leon ^a   Swierczynski, Julian ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Brown adipose tissue; Clofibrate; Fatty acid synthase; Lipogenesis; Liver; Malic enzyme; mRNA; Rat; White adipose tissue

Indexed keywords

CLOFIBRATE; FATTY ACID SYNTHASE; MALATE DEHYDROGENASE (DECARBOXYLATING); MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; GENE EXPRESSION; HYPERLIPIDEMIA; LIPOGENESIS; LIVER; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ANIMALS; ANTILIPEMIC AGENTS; BLOTTING, NORTHERN; CHOLESTEROL; CLOFIBRATE; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPIDS; LIVER; MALATE DEHYDROGENASE; MALE; ORGAN SPECIFICITY; RATS; RATS, WISTAR; RNA; RNA, MESSENGER; TRIGLYCERIDES;

EID: 0032963678     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00129-6     Document Type: Article

References (41)

1. Adams L.L., Webb W.W., Fallon H.J. Inhibition of hepatic triglyceride formation by clofibrate. J. Clin. Invest. 50:1971;2339-2346.
2. Augustyn J.M., Fritz K.E., Daoud A.S., Jarmolych J., Lee K.T. Biochemical effects of moderate diet and clofibrate on swine atherosclerosis. Arch. Pathol. Lab. Med. 102:1978;294-297.
3. Baldwin J.R., Witiak D.T., Feller D.R. Disposition of clofibrate in the rat. Acute and chronic administration. Biochem. Pharmacol. 29:1980;3143-3154.
4. Blennemann B., Moon Y.K., Freake H.C. Tissue-specific regulation of fatty acid synthesis by thyroid hormone. Endocrinology. 130:1992;637-643.
5. Blennemann B., Leahy P., Kim T.S., Freake H.C. Tissue-specific regulation of lipogenic mRNAs by thyroid hormone. Mol. Cell Endocrinol. 110:1995;1-8.
6. Capuzzi D.H., Lackman R.D., Uberti M.O., Reed M.A. Stimulation of hepatic triglyceride synthesis and secretion by clofibrate. Biochem. Biophys. Res. Commun. 60:1974;1499-1508.
7. Castelein H., Gulick T., Declercq P.E., Mannaerts G.P., Moore D.D., Baes M.I. The peroxisome proliferator-activated receptor regulates malic enzyme gene expression. J. Biol. Chem. 269:1994;26754-26758.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Duncan C.H., Best M.M. Stimulation of hepatic synthesis of fatty acids by clofibrate and by a tetralin phenoxy isobutyric acid. Circulation. 39-40(III):1969;6. Suppl.
10. Giocoli G., Tepperman H.M., Tepperman J. Effects of p-chlorophenoxyisobutyric acid (CPIB) on adipose tissue triglycerides synthesis, lipogenesis, and some related enzymes. Proc. Soc. Biol. Med. 138:1971;512-516.
11. Heller F., Harvengt C. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipidaemic subjects. Eur. J. Pharmacol. 25:1983;57-63.
12. Hertz R., Nikodem V., Ben-Ishai A., Berman I., Bar-Tana J. Thyromimetic mode of action of peroxisome proliferators: activation of 'malic' enzyme gene transcription. Biochem. J. 319:1996;241-248.
13. IJpenberg A., Jeannin E., Wahli W., Desvergne B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. J. Biol. Chem. 272:1997;20108-20117.
14. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
15. Kochan Z., Swierczynski J. Development changes of lipogenic enzyme activities and lipogenesis in brown adipose tissue and liver of the rat. Comp. Biochem. Physiol. 101B:1992;283-288.
16. Kochan Z., Bukato G., Swierczynski J. Inhibition of lipogenesis in rat brown adipose tissue by clofibrate. Biochem. Pharmacol. 46:1993;1501-1506.
17. Laker M.E., Mayes P.A. The immediate and long-term effects of clofibrate on the metabolism of the perfused rat liver. Biochem. Pharmacol. 28:1979;2813-2827.
18. Lamb R.G., Fallon H.J. Inhibition of monoacylglycerolphosphate formation by chlorophenoxyisobutyrate and β-benzalbutyrate. J. Biol. Chem. 247:1972;1281-1287.
19. Lewis, B., 1983. Disorders of lipid transport. In: Weatheral, D.J., Ledingham, J.G.G., Warrel, D.A. (Eds.), Oxford Textbook of Medicine. Oxford Univ. Press, Oxford, pp. 985-970.
20. Magnuson M.A., Morioka H., Tecce M.F., Nikodem V.M. Coding nucleotide sequence of rat liver malic enzyme mRNA. J. Biol. Chem. 261:1986;1183-1186.
21. Maragoudakis M.E. Inhibition of hepatic acetyl-CoA carboxylase by hypolipidaemic agents. J. Biol. Chem. 244:1969;5005-5013.
22. Martini S., Valerio G., Fellin R., Baggio G., Gasparotto A., Baiocchi M.R., Baldo G., Crepaldi G. Bezafibrate and clofibrate: effects on plasma lipids, lipoproteins and apoproteins compared in familial hypercholesterolemia. Curr. Ther. Res. 31:1982;354-361.
23. Maxwell R.E., Nawrocki J.W., Uhlendorf P.D. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats. Atherosclerosis. 48:1983;195-203.
24. Mercer S.W., Williamson D.H. The influence of starvation and natural refeeding on the rate of triacylglycerol/fatty acid substrate cycling in brown adipose tissue and different white adipose site of the rat in vivo. The role of insulin and the sympathetic nervous system. Biosci. Rep. 8:1988;147-153.
25. Mishkel M.A., Webb W.F. The mechanism underlying the hypolipidaemic effects of Atromid S, nicotinic acid and benzmolecene-I. Biochem. Pharmacol. 16:1967;897-905.
26. Miyazawa S., Sakurai T., Imura M., Hashimoto T. Effects of ethyl p-chlorophenoxyisobutyrate on carbohydrate and fatty acid metabolism in rat liver. J. Biochem. 78:1975;1171-1176.
27. O'Brien M., Patel S.T., Mukhopadhyay A., Newman H.A.I., Feller D.R., Kokrady S.S., Witiak D.T., Lanese R.R., Rice J.C. Hypolipidaemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals. Lipids. 16:1981;903-911.
28. Platt D.S., Cockrill B.L. Changes in the liver concentrations of the nicotinamide adenine dinucleotide coenzymes and in the activities of oxidoreductase enzymes following treatment of the rat with ethyl chlorophenoxyisobutyrate (Atromid S). Biochem. Pharmacol. 15:1966;927-935.
29. Ren B., Thelen A.P., Peters J.M., Gonzales F.J., Jump D.B. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor α J. Biol. Chem. 272:1997;26827-26832.
30. Richert D.A., Westerfeld W.W. Growth and liver glycerophosphate dehydrogenase responses to thyroxine and p-chlorophenoxyisobutyrate. Endocrinology. 87:1970;1274-1281.
31. Schoonjans K., Staels B., Grimaldi P., Auwerx J. Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur. J. Biochem. 216:1993;615-622.
32. Schoonjans K., Staels B., Auwerx J. The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302:1996;93-109.
33. Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator-activated receptors (PPARs) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:1996;907-925.
34. Shirai K., Ishikawa Y., Nishide T., Sasaki N., Murano S., Matsuoka N., Saito Y., Yoshida S. Effects of clinofibrate on lipid metabolism of aorta in atherosclerotic rats. Artery. 12:1983;145-155.
35. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J.-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98:1998;2088-2093.
36. Stansbie D., Brownsey R.W., Crettaz M., Denton R.M. Acute effect in vivo of anti-insulin serum on rates of fatty acid synthesis activities of acetyl-Coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose of fed rats. Biochem. J. 160:1976;413-416.
37. Trayhurn P. Fatty acid synthesis in brown adipose tissue in relation to whole body synthesis in the cold-acclimated golden hamster (Mesocricetus auratus). Biochim. Biophys. Acta. 620:1980;10-17.
38. Zakim D., Paradini R.S., Herman R.H. Effect of clofibrate (ethyl-chlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat. Biochem. Pharmacol. 19:1970;305-310.
39. Zelewski M., Swierczynski J. The effect of clofibrate feeding on the NADP-linked dehydrogenases activity in the rat tissue. Biochim. Biophys. Acta. 785:1983;152-157.
40. Zelewski M., Swierczynski J. The influence of prolonged clofibrate treatment on plasma drug concentration and liver NADP-linked enzymes activity. Gen. Pharmacol. 17:1986;117-119.
41. Zelewski M., Swierczynski J. Clofibrate feeding increases cytoplasmic but not mitochondrial malic enzyme activity in rat kidney cortex. Cell Biochem. Funct. 7:1989;97-103.